Our interdisciplinary “Tox-Board” meets once a month. In an interdisciplinary panel of neurologists, cardiologists, rheumatologists, gastroenterologists, endocrinologists, hematooncologists and dermatologists we discuss complex, severe, rare and therapy- refractory immune-related side effects of immunotherapy (irAE).
Subsequently we give recommendations to the treating physician. Within this panel we also establish internal guidelines to improve side effect management and initiate scientific projects to further investigate pathogenetic mechanisms of irAE.
Myocarditis induced by Immunotherapy
Document
Document
Immune Checkpoint Inhibitors and Kidney Toxicity
Document
Checkpoint-inhibitor induced Polyserositis
Document
Guidelines
ASCO-Guideline
Document
ESMO-Guideline
Document
Document
NCCN-Guideline
Document
Monitoring of immunotherapy
Document
Document